
Hosted by Pharmacy Podcast Network · EN
Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.
Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.
Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.
PPN is a division of RxPR, LLC. Copyright 2026

PBM Reform Podcast Sponsored by American Pharmacy Cooperative, Inc. (APCI) Host: Greg Reybold Special Guest: Ben Mudd, PharmD, Executive Director, Kentucky Pharmacists Association Momentum for meaningful pharmacy benefit manager reform is building in Washington. In this episode of the PBM Reform Podcast, host Greg Reybold welcomes Dr. Ben Mudd, Executive Director of the Kentucky Pharmacists Association, to examine the bipartisan Pharmacists Fight Back Act, H.R. 6610, and what its advancement could mean for patients, pharmacists, employers, and the future of independent pharmacy. On July 22, 2026, the House Committee on Oversight and Government Reform reported the legislation favorably following a committee markup. Introduced by Chairman James Comer of Kentucky and Representative Jake Auchincloss of Massachusetts, the bill would establish new requirements for pharmacy benefit managers participating in the Federal Employees Health Benefits Program. The proposed reforms would require participating PBMs to provide fair pharmacy reimbursement, apply manufacturer rebates toward reducing beneficiaries’ prescription drug costs, prohibit patient steering to PBM-affiliated pharmacies, increase transparency, and establish penalties for noncompliance. Greg and Ben discuss why the Federal Employees Health Benefits Program could become an important proving ground for broader PBM accountability and how federal action may influence commercial plans, state legislation, and future healthcare policy. Episode Discussion The conversation explores: Why H.R. 6610 has attracted bipartisan support How PBM reimbursement practices threaten independent pharmacy sustainability The impact of patient steering and PBM-affiliated pharmacy networks Why manufacturer rebates should directly reduce patients’ prescription costs What “fair reimbursement” must include to protect pharmacy access How enforcement provisions and financial penalties could improve accountability Kentucky’s role in advancing pharmacy and PBM reform The connection between federal legislation and state-level advocacy What pharmacists should communicate to legislators and patients The remaining steps required before H.R. 6610 can become law Dr. Mudd brings the perspective of a practicing community pharmacist and association executive who has worked extensively in pharmacy advocacy. A graduate of the University of Kentucky College of Pharmacy, he practiced in both chain and independent pharmacy settings before assuming leadership of the Kentucky Pharmacists Association. Ben is running for Kentucky State Senate position this November. Lear more about his platform and issues most important: https://www.votemudd.com/meet-ben Key Takeaway PBM reform is no longer simply an industry debate. It is a patient-access, healthcare-affordability, pharmacy-choice, and community-infrastructure issue. The Pharmacists Fight Back Act represents a significant federal effort to separate PBM compensation from practices that may increase drug costs, restrict patient choice, and financially disadvantage independent pharmacies. The legislation’s advancement is an important milestone—but pharmacists must remain informed, engaged, and vocal as the bill moves through the legislative process. Subscribe to the PBM Reform Podcast for continuing coverage of legislation, regulation, litigation, and advocacy shaping the future of pharmacy benefit management and community pharmacy. The PBM Reform Podcast is sponsored by American Pharmacy Cooperative, Inc., supporting independent pharmacies and advocating for a more transparent, competitive, and patient-centered prescription drug marketplace.

Psychedelics, hallucinogens, natural medicines, you name it, we’re covering it on this episode of the Pain Pod folks! We’ll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin’ just learnin’! You’re not going to want to miss this one! Come one, come all, to the Pain Pod!!! Pain Guy www.painguy.us

The Independent Pharmacy Cooperative is partnering with Fullscript to help independent pharmacies expand their wellness offerings without adding inventory, storage costs, or fulfillment responsibilities. Through the partnership, IPC members receive free access to Fullscript’s digital platform, featuring more than 375 trusted supplement brands. Pharmacies can recommend personalized wellness protocols, earn approximately 35% margins on online sales, and benefit from direct-to-patient shipping, automated refill reminders, and optional auto-ship services. Fullscript manages product inventory, payment processing, and delivery, giving independent pharmacies a practical way to generate recurring revenue while supporting patient adherence and long-term wellness goals. Guests: Kelli - IPC Christopher - FullScript Shannon - IPC Andrea - Pharmacy Owner Emlah Tubuo - Pharmacy Owner

In this episode, host Jon Grice takes a candid and timely look at the evolving role of Medication Therapy Management (MTM) in community pharmacy. Jon raises an important question: Are pharmacists missing a critical opportunity hiding in plain sight? He explores why MTM remains essential—not just for patient care, but for the financial sustainability of today’s pharmacies. He discusses the shifting landscape where dispensing margins have eroded, clinical services have become the new value driver, and yet emotional and historical frustrations with payers may be holding some pharmacists back from embracing what’s next. Drawing on conversations with industry leaders and his own lived experience as an independent pharmacist, Jon challenges listeners to re‑examine assumptions, recognize cognitive biases, and reconnect with the shared goals of insurers, pharmacies, and patients. Whether you're a chain pharmacist, an independent owner, or someone trying to understand the future of clinical care, this episode offers a grounded, honest look at where MTM stands—and where it needs to go next.

Chris Antypas, PharmD and President of Asti’s South Hills Pharmacy in Pittsburg, PA, along with his partners are launching Medesto Heath. This totally new type of technology will allow pharmacist to combine prescription data, lab results, clinical notes and other health metrics and determine if the medications a patient is taking are actually working. This is way more than adherence and MTM. It is a totally new paradigm for pharmacy care. Antypas is joined by Robyn Amberg who has known Antypas for several years and proposed this podcast.

Independent pharmacies are facing growing reimbursement uncertainty, especially when dispensing high-cost brand medications such as GLP-1 therapies. In this exclusive Pharmacy Podcast Network special feature, we examine how GoodRx Community Link provides independent pharmacies with predictable pricing and favorable economics across both brand and generic medications, ultimately helping pharmacies remain solvent while providing consumers affordable prescription prices. Todd Eury is joined by David Graziano, Head of Retail Network at GoodRx, and Tom DePietro, independent pharmacy owner at DePietro’s Pharmacy, for a practical discussion about the pressures affecting independent pharmacy and the need for reimbursement models that support pharmacy viability. The conversation explores how Community Link supports brand medications through manufacturer-funded savings that flow back to the pharmacy through GoodRx, while the manufacturer covers the administrative fee. For generic medications, the program uses a NADAC-based cost-plus model intended to provide clearer visibility into reimbursement. Listeners will also hear how independent pharmacies are impacted by rising deductibles, prior authorizations, narrow formularies, cash-pay growth, and increased competition. David and Tom discuss the importance of transparent pricing, digital engagement, streamlined fulfillment, personalized patient care, and sustainable economics for local pharmacies. Key discussion points include: The financial risk of dispensing high-cost brand medications like GLP-1s Predictable reimbursement for brands and generics The role of manufacturer-funded savings for brand medications NADAC-based cost-plus pricing for generics Pharmacy access to GLP-1 cash-pay programs Competing through service, technology, and patient relationships Protecting local healthcare access through independent pharmacy Explore how GoodRx Community Link can bring greater transparency and predictability to brand and generic dispensing, helping independent pharmacies serve patients sustainably and with confidence. Featured Guests: David Graziano — Head of Retail Network, GoodRx Tom DePietro — Independent Pharmacy Owner, DePietro’s Pharmacy Host: Todd Eury — Founder, Pharmacy Podcast Network Visit goodrx.com/CommunityLink to learn more GoodRx is NOT insurance.

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered. McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy. Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends. Thank you to AAPA, for sponsoring this coverage! In this episode we hear from: Kate Helf - IPC Nancy Lyons - McKesson Mackenzie Hernandez - NimbleRx Mohan Gulati, CEO - Thinkrr.ai Ryan Spaulding, VP Sales - Lumistry Veronica German - McKesson Alex Berce - Good Value Pharmacy Crystal Lennartz, President - Health Mart & Health Mart Atlas Kerolos Ekladious - TJM Labs Marc Essensa, CEO - IPC

In this episode, host Ross Frey, Senior Product Manager and resident MTM/CMR strategist, sits down with Cindy Henry, Director of Payer Products at Outcomes, to unpack one of the biggest changes hitting Medicare Advantage plans: CMS’s intent to return the CMR completion rate to the Star Ratings program beginning in measure year 2027. Ross and Cindy explore how the industry reacted to the latest CMS Advance Notice, why the CMR measure’s return matters, and how MTM strategy has quietly shifted during its two‑year placement on the display page. Together, they outline the pressures plans are feeling—from shrinking margins to rising expectations around clinical quality—and the renewed focus on the value of medication therapy management, total cost of care, and local pharmacy engagement. A key topic throughout the episode is the impact of CMS’s expanded MTM eligibility criteria, which significantly increases denominators for 2025 and beyond. Cindy explains how this shift forces payers to rethink scale, budget, ROI, and operational models, while Ross shares Outcomes’ cut‑point predictions and how performance is likely to redistribute once the measure becomes active again. The conversation also highlights Outcomes’ strategy to support both health plans and community pharmacies as they prepare for 2027. Ross describes work underway to reduce documentation burden, streamline workflows, leverage new technology, and allow pharmacists to practice at the top of their license—ultimately helping MTM delivery scale without sacrificing quality. By the end of the episode, the message is clear: Plans that begin modeling, staffing, vendor alignment, and workflow modernization now will be best positioned when Star Ratings recalibrate in 2029. Listeners are encouraged to explore Outcomes’ latest prediction models and analysis at outcomes.com

I was blown away by my conversation with today’s guest, who discovered that without HEALTH you have nothing... He became a Jack Of All Trades and subsequently an inventor that has changed entire venues with his innovations. He has fully recovered his health thanks to one of his own inventions, and is now on a mission to help people optimize their health to enjoy living! George Wiseman is an inventor, engineer, and founder of Eagle-Research, best known for his decades of work developing Brown’s Gas technology for both energy and emerging wellness applications. Raised as a rancher’s son in a remote, off-grid environment, George learned early how to build, repair, and survive with limited resources, which influenced his lifelong commitment to practical and reliable innovation. After leaving the ranch in the late 1970s, he pursued a path in alternative energy and automotive systems, eventually specializing in fuel efficiency and combustion technologies. In the 1980s, he began developing Brown’s Gas systems that could significantly improve fuel economy and even replace traditional torch gases at a fraction of the cost. Over time, George’s work took an unexpected turn as customers began reporting potential health-related effects from the technology—something he initially dismissed. Years later, after personally experimenting with the applications and witnessing growing anecdotal results, he shifted his focus toward exploring its broader potential and developed his at-home device, AquaCure. This mission became deeply personal following the loss of his wife after a long battle with Lupus, which intensified his commitment to sharing what he had learned. Today, George is driven by a singular goal: to make his technology accessible to as many people as possible.

Specialty pharmacy is becoming one of the most important access points in modern healthcare, particularly for patients managing complex, chronic, rare, and high-cost conditions. As therapies advance and patient needs become more sophisticated, health systems are rethinking how specialty pharmacy can improve medication access, continuity of care, clinical outcomes, affordability, and the overall patient experience. In this special episode of This Week in Pharmacy, the Pharmacy Podcast Network introduces Specialty Care Close to Home, a new series examining how hospitals and health systems are designing, building, supporting, and scaling specialty pharmacy services across health-system and community-based care models. Featured Guests Dr. Laura Mark, PharmD Vice President of Pharmacy, Allegheny Health Network Allison Arant Senior Vice President, Clearway Health Chris Corsi Chief Executive Officer, CassianRx Together, the guests discuss why health-system specialty pharmacy expansion matters, what successful programs require, and where the greatest strategic and operational challenges exist. The conversation explores how strong partnerships, integrated clinical workflows, patient-centered technology, and coordinated care teams can reduce fragmentation and improve specialty medication access. Discussion Highlights The growing strategic role of health-system specialty pharmacy Keeping patients connected to trusted local care teams Improving access, adherence, affordability, and therapy management Building scalable specialty pharmacy infrastructure Integrating clinical, operational, and technology capabilities Overcoming payer, workflow, workforce, and reimbursement challenges Creating collaborative models that support long-term sustainability Future episodes of Specialty Care Close to Home will explore accreditation, payer access, manufacturer relationships, clinical workflow, patient engagement, technology infrastructure, data reporting, community access, workforce development, and financial sustainability. The series will also feature pharmacy directors, vice presidents, executives, operators, and innovators from health systems across the country who are leading the next generation of specialty care delivery. Host: Todd Eury, Founder of the Pharmacy Podcast Network Coming Soon: Specialty Care Close to Home—a national conversation about bringing advanced specialty pharmacy services closer to where patients live, work, and receive care.